163 related articles for article (PubMed ID: 19346959)
1. Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
Harris JN; Bowen DJ; Kuniyuki A; McIntosh L; FitzGerald LM; Ostrander EA; Stanford JL
Genet Med; 2009 May; 11(5):344-55. PubMed ID: 19346959
[TBL] [Abstract][Full Text] [Related]
2. Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
Mayer M; Selig K; Tüttelmann F; Dinkel A; Gschwend JE; Herkommer K
Fam Cancer; 2019 Apr; 18(2):221-230. PubMed ID: 30229510
[TBL] [Abstract][Full Text] [Related]
3. Genetic testing for prostate cancer. Willingness and predictors of interest.
Diefenbach MA; Schnoll RA; Miller SM; Brower L
Cancer Pract; 2000; 8(2):82-6. PubMed ID: 11898181
[TBL] [Abstract][Full Text] [Related]
4. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.
Bratt O; Damber JE; Emanuelsson M; Kristoffersson U; Lundgren R; Olsson H; Grönberg H
Eur J Cancer; 2000 Jan; 36(2):235-41. PubMed ID: 10741283
[TBL] [Abstract][Full Text] [Related]
5. The beliefs, and reported and intended behaviors of unaffected men in response to their family history of prostate cancer.
Cowan R; Meiser B; Giles GG; Lindeman GJ; Gaff CL
Genet Med; 2008 Jun; 10(6):430-8. PubMed ID: 18496220
[TBL] [Abstract][Full Text] [Related]
6. Men's values-based factors on prostate cancer risk genetic testing: a telephone survey.
Doukas DJ; Li Y
BMC Med Genet; 2004 Dec; 5():28. PubMed ID: 15588314
[TBL] [Abstract][Full Text] [Related]
7. Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.
Cormier L; Valéri A; Azzouzi R; Fournier G; Cussenot O; Berthon P; Guillemin F; Mangin P
Prostate; 2002 Jun; 51(4):276-85. PubMed ID: 11987156
[TBL] [Abstract][Full Text] [Related]
8. Genomics of Prostate Cancer: What Nurses Need to Know.
McReynolds KM; Connors LM
Semin Oncol Nurs; 2019 Feb; 35(1):79-92. PubMed ID: 30665733
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer testing in SA men: influence of sociodemographic factors, health beliefs and LUTS.
Weller D; Pinnock C; Silagy C; Hiller JE; Marshall VR
Aust N Z J Public Health; 1998; 22(3 Suppl):400-2. PubMed ID: 9629831
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
[TBL] [Abstract][Full Text] [Related]
11. Men's attitudes regarding genetic testing for hereditary prostate cancer risk.
Miesfeldt S; Jones SM; Cohn W; Lippert M; Haden K; Turner BL; Martin-Fries T; Clark SM
Urology; 2000 Jan; 55(1):46-50. PubMed ID: 10654893
[TBL] [Abstract][Full Text] [Related]
12. Screening for prostate cancer in Dutch hereditary prostate cancer families.
Kiemeney LA; Broeders MJ; Pelger M; Kil PJ; Schröder FH; Witjes JA; Vasen HF
Int J Cancer; 2008 Feb; 122(4):871-6. PubMed ID: 17957791
[TBL] [Abstract][Full Text] [Related]
13. Genetic testing in prostate cancer management: Considerations informing primary care.
Giri VN; Morgan TM; Morris DS; Berchuck JE; Hyatt C; Taplin ME
CA Cancer J Clin; 2022 Jul; 72(4):360-371. PubMed ID: 35201622
[TBL] [Abstract][Full Text] [Related]
14. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing.
Bratt O; Kristoffersson U; Lundgren R; Olsson H
Urology; 1997 Sep; 50(3):360-5. PubMed ID: 9301698
[TBL] [Abstract][Full Text] [Related]
15. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
Xu J
Am J Hum Genet; 2000 Mar; 66(3):945-57. PubMed ID: 10712209
[TBL] [Abstract][Full Text] [Related]
16. Accuracy and completeness in reporting family history of prostate cancer by unaffected men.
Gaff CL; Aragona C; MacInnis RJ; Cowan R; Payne C; Giles GG; Lindeman GJ
Urology; 2004 Jun; 63(6):1111-6. PubMed ID: 15183962
[TBL] [Abstract][Full Text] [Related]
17. Predictors of prostate cancer screening using Andersen's Behavioral Model of Health Services Use.
Ogunsanya ME; Jiang S; Thach AV; Bamgbade BA; Brown CM
Urol Oncol; 2016 Dec; 34(12):529.e9-529.e14. PubMed ID: 27450892
[TBL] [Abstract][Full Text] [Related]
18. Hereditary prostate cancer: clinical aspects.
Bratt O
J Urol; 2002 Sep; 168(3):906-13. PubMed ID: 12187189
[TBL] [Abstract][Full Text] [Related]
19. Why do men refuse or attend population-based screening for prostate cancer?
Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
[TBL] [Abstract][Full Text] [Related]
20. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
